Is nitric oxide involved in cutaneous vasodilation during body heating in humans?

N. M. Dietz, J. M. Rivera, David Oman Warner, Michael Joseph Joyner

Research output: Contribution to journalArticle

58 Citations (Scopus)

Abstract

The neurotransmitter responsible for neurogenic vasodilation in human skin during body heating is unknown. We sought to determine whether the vasodilating substance nitric oxide (NO) is involved in this phenomenon. Six subjects were heated for 50 min by use of a water-perfused suit while forearm blood flow (FBF) was measured with plethysmography and skin blood flow (SkBF) was measured by the laser-Doppler method in both arms. In one forearm, N(G)- monomethyl-L-arginine (L-NMMA), an NO synthase blocker, was infused into the brachial artery. Bolus doses of L-NMMA (≤4 mg/min) for 5 min were given to blunt NO-mediated vasodilator responses to acetylcholine (ACh, 64 μg/min). A continuous infusion of L-NMMA (≤1.0 mg/min) was used during body heating to maintain NO synthase blockade. In the forearm receiving L-NMMA, FBF was 1.8 ± 0.3 ml · 100 ml -1 · min -1 before drug infusion and rose to 9.5 ± 1.3 ml · 100 ml -1 · min -1 with ACh. After L-NMMA infusion, FBF was 1.3 ± 0.2 ml · 100 ml -1 · min -1 and rose to 2.6 ± 0.4 ml · 100 ml -1 · min -1 with ACh (both P < 0.05 vs. pre-L-NMMA). Similar changes in SkBF were seen with ACh and L-NMMA, confirming that the drugs reached cutaneous vessels. With body heating, oral temperature increased by 1.2°C, heart rate increased by 34 beats/min, and mean arterial pressure remained constant at ~ 75 mmHg. FBF in the treated forearm rose to 11.5 ± 2.1 vs. 12.6 ± 1.7 ml · 100 ml -1 · min -1 in the control forearm (P > 0.05, control vs. treated response). These FBF responses were also similar to those in control studies without drug administration. SkBF responses to heating were also similar in both forearms. At the end of heating, variable dilator responses to repeat doses of ACh were observed. However, increases in blood flow with heating were similar bilaterally in the subjects whose dilator responses to ACh were blocked at the end of heating. These data suggest that NO does not play a major role in cutaneous vasodilation during body heating in humans.

Original languageEnglish (US)
Pages (from-to)2047-2053
Number of pages7
JournalJournal of Applied Physiology
Volume76
Issue number5
StatePublished - 1994

Fingerprint

Forearm
Vasodilation
Heating
omega-N-Methylarginine
Nitric Oxide
Skin
Nitric Oxide Synthase
Pharmaceutical Preparations
Plethysmography
Brachial Artery
Vasodilator Agents
Acetylcholine
Neurotransmitter Agents
Arginine
Arterial Pressure
Lasers
Arm
Heart Rate
Temperature
Water

Keywords

  • autonomic nervous system
  • cutaneous blood flow
  • thermoregulation

ASJC Scopus subject areas

  • Endocrinology
  • Physiology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Is nitric oxide involved in cutaneous vasodilation during body heating in humans? / Dietz, N. M.; Rivera, J. M.; Warner, David Oman; Joyner, Michael Joseph.

In: Journal of Applied Physiology, Vol. 76, No. 5, 1994, p. 2047-2053.

Research output: Contribution to journalArticle

@article{a7f3a98e24f84886944748f85f841b80,
title = "Is nitric oxide involved in cutaneous vasodilation during body heating in humans?",
abstract = "The neurotransmitter responsible for neurogenic vasodilation in human skin during body heating is unknown. We sought to determine whether the vasodilating substance nitric oxide (NO) is involved in this phenomenon. Six subjects were heated for 50 min by use of a water-perfused suit while forearm blood flow (FBF) was measured with plethysmography and skin blood flow (SkBF) was measured by the laser-Doppler method in both arms. In one forearm, N(G)- monomethyl-L-arginine (L-NMMA), an NO synthase blocker, was infused into the brachial artery. Bolus doses of L-NMMA (≤4 mg/min) for 5 min were given to blunt NO-mediated vasodilator responses to acetylcholine (ACh, 64 μg/min). A continuous infusion of L-NMMA (≤1.0 mg/min) was used during body heating to maintain NO synthase blockade. In the forearm receiving L-NMMA, FBF was 1.8 ± 0.3 ml · 100 ml -1 · min -1 before drug infusion and rose to 9.5 ± 1.3 ml · 100 ml -1 · min -1 with ACh. After L-NMMA infusion, FBF was 1.3 ± 0.2 ml · 100 ml -1 · min -1 and rose to 2.6 ± 0.4 ml · 100 ml -1 · min -1 with ACh (both P < 0.05 vs. pre-L-NMMA). Similar changes in SkBF were seen with ACh and L-NMMA, confirming that the drugs reached cutaneous vessels. With body heating, oral temperature increased by 1.2°C, heart rate increased by 34 beats/min, and mean arterial pressure remained constant at ~ 75 mmHg. FBF in the treated forearm rose to 11.5 ± 2.1 vs. 12.6 ± 1.7 ml · 100 ml -1 · min -1 in the control forearm (P > 0.05, control vs. treated response). These FBF responses were also similar to those in control studies without drug administration. SkBF responses to heating were also similar in both forearms. At the end of heating, variable dilator responses to repeat doses of ACh were observed. However, increases in blood flow with heating were similar bilaterally in the subjects whose dilator responses to ACh were blocked at the end of heating. These data suggest that NO does not play a major role in cutaneous vasodilation during body heating in humans.",
keywords = "autonomic nervous system, cutaneous blood flow, thermoregulation",
author = "Dietz, {N. M.} and Rivera, {J. M.} and Warner, {David Oman} and Joyner, {Michael Joseph}",
year = "1994",
language = "English (US)",
volume = "76",
pages = "2047--2053",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "5",

}

TY - JOUR

T1 - Is nitric oxide involved in cutaneous vasodilation during body heating in humans?

AU - Dietz, N. M.

AU - Rivera, J. M.

AU - Warner, David Oman

AU - Joyner, Michael Joseph

PY - 1994

Y1 - 1994

N2 - The neurotransmitter responsible for neurogenic vasodilation in human skin during body heating is unknown. We sought to determine whether the vasodilating substance nitric oxide (NO) is involved in this phenomenon. Six subjects were heated for 50 min by use of a water-perfused suit while forearm blood flow (FBF) was measured with plethysmography and skin blood flow (SkBF) was measured by the laser-Doppler method in both arms. In one forearm, N(G)- monomethyl-L-arginine (L-NMMA), an NO synthase blocker, was infused into the brachial artery. Bolus doses of L-NMMA (≤4 mg/min) for 5 min were given to blunt NO-mediated vasodilator responses to acetylcholine (ACh, 64 μg/min). A continuous infusion of L-NMMA (≤1.0 mg/min) was used during body heating to maintain NO synthase blockade. In the forearm receiving L-NMMA, FBF was 1.8 ± 0.3 ml · 100 ml -1 · min -1 before drug infusion and rose to 9.5 ± 1.3 ml · 100 ml -1 · min -1 with ACh. After L-NMMA infusion, FBF was 1.3 ± 0.2 ml · 100 ml -1 · min -1 and rose to 2.6 ± 0.4 ml · 100 ml -1 · min -1 with ACh (both P < 0.05 vs. pre-L-NMMA). Similar changes in SkBF were seen with ACh and L-NMMA, confirming that the drugs reached cutaneous vessels. With body heating, oral temperature increased by 1.2°C, heart rate increased by 34 beats/min, and mean arterial pressure remained constant at ~ 75 mmHg. FBF in the treated forearm rose to 11.5 ± 2.1 vs. 12.6 ± 1.7 ml · 100 ml -1 · min -1 in the control forearm (P > 0.05, control vs. treated response). These FBF responses were also similar to those in control studies without drug administration. SkBF responses to heating were also similar in both forearms. At the end of heating, variable dilator responses to repeat doses of ACh were observed. However, increases in blood flow with heating were similar bilaterally in the subjects whose dilator responses to ACh were blocked at the end of heating. These data suggest that NO does not play a major role in cutaneous vasodilation during body heating in humans.

AB - The neurotransmitter responsible for neurogenic vasodilation in human skin during body heating is unknown. We sought to determine whether the vasodilating substance nitric oxide (NO) is involved in this phenomenon. Six subjects were heated for 50 min by use of a water-perfused suit while forearm blood flow (FBF) was measured with plethysmography and skin blood flow (SkBF) was measured by the laser-Doppler method in both arms. In one forearm, N(G)- monomethyl-L-arginine (L-NMMA), an NO synthase blocker, was infused into the brachial artery. Bolus doses of L-NMMA (≤4 mg/min) for 5 min were given to blunt NO-mediated vasodilator responses to acetylcholine (ACh, 64 μg/min). A continuous infusion of L-NMMA (≤1.0 mg/min) was used during body heating to maintain NO synthase blockade. In the forearm receiving L-NMMA, FBF was 1.8 ± 0.3 ml · 100 ml -1 · min -1 before drug infusion and rose to 9.5 ± 1.3 ml · 100 ml -1 · min -1 with ACh. After L-NMMA infusion, FBF was 1.3 ± 0.2 ml · 100 ml -1 · min -1 and rose to 2.6 ± 0.4 ml · 100 ml -1 · min -1 with ACh (both P < 0.05 vs. pre-L-NMMA). Similar changes in SkBF were seen with ACh and L-NMMA, confirming that the drugs reached cutaneous vessels. With body heating, oral temperature increased by 1.2°C, heart rate increased by 34 beats/min, and mean arterial pressure remained constant at ~ 75 mmHg. FBF in the treated forearm rose to 11.5 ± 2.1 vs. 12.6 ± 1.7 ml · 100 ml -1 · min -1 in the control forearm (P > 0.05, control vs. treated response). These FBF responses were also similar to those in control studies without drug administration. SkBF responses to heating were also similar in both forearms. At the end of heating, variable dilator responses to repeat doses of ACh were observed. However, increases in blood flow with heating were similar bilaterally in the subjects whose dilator responses to ACh were blocked at the end of heating. These data suggest that NO does not play a major role in cutaneous vasodilation during body heating in humans.

KW - autonomic nervous system

KW - cutaneous blood flow

KW - thermoregulation

UR - http://www.scopus.com/inward/record.url?scp=0028308832&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028308832&partnerID=8YFLogxK

M3 - Article

C2 - 7520431

AN - SCOPUS:0028308832

VL - 76

SP - 2047

EP - 2053

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 5

ER -